National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIAAA Protocol NCIG 001: A Multisite Double-Blind, Placebo-Controlled Trial of Quetiapine Fumarate XR in Very Heavy-Drinking Alcohol-Dependent Patients Study Details This double-blind, randomized placebo-controlled trial evaluated the efficacy and safety of quetiapine, for the treatment of alcohol use disorder (AUD). Sponsor: The National Institute on Alcohol Abuse and Alcoholism’s Clinical Investigations Group (NCIG) NCT #: 00498628 Phase: Phase 2 Treatment...
Purpose To provide grant applicants with guidance and information on the development of data and safety monitoring plans (DSMP) for NIH-defined clinical trials funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Introduction In June 1998, the National Institutes of Health (NIH) issued a policy on data and safety monitoring requiring oversight and monitoring of all NIH funded...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, is the primary U.S. agency for conducting and supporting research on the causes, consequences, diagnosis, prevention, and treatment of alcohol use disorder. Each year, NIAAA submits its budget request to NIH. This request is incorporated into the full NIH budget request, which is sent...